Fernanda Russo
Papers
1
Total Citations
4
H-Index
1
About
Fernanda Russo is a clinical researcher whose work centers on improving patient-reported outcomes in prostate cancer care, with a particular focus on quality-of-life assessment and psychometric validation. Her major contribution is the validation of the Portuguese version of the Expanded Prostate Cancer Index Composite for Clinical Practice (EPIC-CP), a streamlined tool designed to capture functional outcomes in routine clinical settings. In her landmark 2020 study, Russo demonstrated the instrument’s reliability and clinical utility by prospectively evaluating early functional recovery in patients at a single institution. Though her citation count is still growing—with her most-cited paper accumulating 4 citations—her work addresses a critical gap in culturally adapted, practical assessment tools for Portuguese-speaking populations. By enabling clinicians to systematically track urinary, bowel, sexual, and hormonal domains, Russo’s research supports more personalized follow-up care and enhances the integration of patient perspectives into everyday oncology practice. Her efforts are particularly valuable for researchers and clinicians seeking validated, concise instruments that bridge the gap between rigorous research and real-world clinical application.
Research Focus
Key Achievements
Top Papers
- 1